Avextra Unveils its Alliance for Evidence and Announces its Support of BELCANTO: A Clinical Trial for Oncology Patients Avextra is launching its Alliance for Evidence-based Cannabis Medicine: a platform focused on collaborating with healthcare professionals and researchers to generate real-world patient data with the...

Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria Avextra has signed distribution agreements with two pharmaceutical distribution partners in Switzerland and one partner in AustriaAvextra begins exports of standardized cannabis-based medicines from...

Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy Avextra has successfully exported EU-GMP standardised cannabis extracts manufactured at its German facility to its distribution partner in ItalyAvextra extracts are the first Made in Germany products...

Avextra AG Announces Closing of EU 17 Million Capital Raise Avextra announces the closing of its EU 17 Million Convertible Loan Note (“CLN”) bridge capital raise. The CLN will automatically swap into equity at the next capital round currently in preparation. ...

Avextra Successfully Exports Oil-Based Cannabis Medicines to the United Kingdom Avextra successfully exported EU-GMP standardised cannabis extracts manufactured in its German facility to its distribution partner in the United Kingdom Export is a significant milestone that...